GEKO Venous Thromboembolism Prevention Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.

Also called NCT05476913

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05476913
  • ISRCTN ISRCTN11175235
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05476913. Randomized; single masking; primary purpose prevention. Start 2023-07-06 (actual); primary completion 2025-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GEKO Venous Thromboembolism Prevention Study
Condition
Stroke, Acute
Condition
Venous Thromboembolism
Intervention (Device)
geko™ device
Lead sponsor
Firstkind Ltd (class: industry)
Collaborator
National Institute for Health Research, United Kingdom (class: other government)
Collaborator
Keele University (class: other)
Collaborator
University Hospitals of North Midlands NHS Trust (class: other)
Collaborator
University of California (class: other)
Collaborator
Bournemouth University (class: other)

Record details

Record id
cardio:ct-nct05476913
Content hash
f96c8fe705f77e2f5fe4663804f7e94a0c815253d4235b851994e39d049584f6